A 2022 PLOS ONE study found 63.2% of people reported needle phobia. BioNxt is working on a sublingual semaglutide film, though such formats aren't FDA approved.
Recap by typeshit. Full story at health.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
Nestlé is building nutrition products for GLP-1 users, and Circana says alcohol volumes are falling while high-protein, smaller-pack foods gain.
10:37
PBS NewsHour reports on the growing research into whether GLP-1 medications could help with addiction to alcohol and other drugs.
Loading…